Suc-Leu-Leu-Val-Tyr-7-amino-4-trifluoromethylcoumarin
- Empirical Formula: C40H50F3N5O10
- Molecular Weight: 817.85
- MDL number: MFCD03453017
- Update Date: 2026-09-12 18:54:40
What is Suc-Leu-Leu-Val-Tyr-7-amino-4-trifluoromethylcoumarin?
Biochem/physiol Actions
Chymotrypsin and multicatalytic endopeptidase complex: proteasome substrate similar to AMC derivative
Properties of Suc-Leu-Leu-Val-Tyr-7-amino-4-trifluoromethylcoumarin
| storage temp. | -20°C |
| form | solid |
Safety information for Suc-Leu-Leu-Val-Tyr-7-amino-4-trifluoromethylcoumarin
Computed Descriptors for Suc-Leu-Leu-Val-Tyr-7-amino-4-trifluoromethylcoumarin
New Products
5-bromo-4-fluoro-2-nitrobenzaldehyde (R)-(-)-2-Amino-1-propanol Cyclobutanone Fmoc-OSu 1-(2-Chloroethyl)pyrrolidine Hydrochloride 2-Amino-2-(4-methylphenyl)acetic acid β-Bromostyrene Ethyl 3-phenylpropanoate Phenethyl cinnamate Dipropyl disulfide 4 pentyn 1 ol N-Vinylformamide Methacrylate-PEG-Methacrylate, Mn:35000 2,4-Dihydroxyacetophenone 2-Chloro 5-Fluoro Pyridine Vasicinone 2-Chloroisonicotinic Acid Tween 80 or Polysorbate 80 2-Butyn-1-oL 2-Pentyn-1-oL 4-Nitrobenzotrifluoride N-(4-fluoro-2-methoxy-5-nitrophenyl)-4-(1-methyl-1H-indol-3-yl)pyrimidin-2-amine Pirtobrutinib intd. N-(4-Cyano-3-(trifluoromethyl)phenyl)-2-methyloxirane-2-carboxamideYou may like
-
N-Succinyl-Leu-Leu-Val-Tyr-7-amido-4-trifluoromethylcoumarin CASView Details -
Fmoc-OSu 98+View Details
82911-69-1 -
7250-67-1 1-(2-Chloroethyl)pyrrolidine Hydrochloride 98+View Details
7250-67-1 -
13227-01-5 98+View Details
13227-01-5 -
7250-67-1 1-(2-Chloroethyl)pyrrolidine Hydrochloride 98+View Details
7250-67-1 -
13227-01-5 98+View Details
13227-01-5 -
7250-67-1 1-(2-Chloroethyl)pyrrolidine Hydrochloride 98+View Details
7250-67-1 -
13227-01-5 98+View Details
13227-01-5
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
